Top

Gepubliceerd in:

01-05-2010 | Editorial

Safety of dual antiplatelet therapy in daily cardiology practice

Auteur: F. W. A. Verheugt

Gepubliceerd in: Netherlands Heart Journal | Uitgave 5/2010

Abstract

Dual antiplatelet therapy has become the cornerstone of the treatment of acute coronary syndromes with or without stent implantation.

vorige artikel Discrimination of the elderly: how guilty are you?

volgende artikel Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy

Van de Werf F. New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome? Eur Heart J. 2009;30:1695-702.

Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non ST-elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-660.

CURE Investigators. Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.

COMMIT(Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1607-2.

ACTIVE Investigators. Effect of clopidogrel added to aspirin in atrial fibrillation. N Engl J Med. 2009;360;1266-78.

Verheugt FWA. Good old warfarin for stroke prevention in atrial fibrillation. Lancet. 2006;367:1877-8.

Fox KAA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) trial. Circulation. 2004;110:1202-8.

Douketis JD, Berger PB, Dunn AS, et al. Perioperative management of antithrombotic therapy: American College of Chest Physician evidence-based clinical practice guidelines (8^th edition). Chest. 2009;133(Suppl 6):299S-339S.

Przybylski A, Derejko P, Kwasniewski W, Urbańczyk-Świć D, Zakrzewska J, Orszulak W, et al. Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: the results of a prospective, two-centre registry. Neth Heart J. 2010;18:230-235.

10.

Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use of recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation. 2004;110:2361-7.

11.

Van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et a. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53:1399-409.

12.

Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol. 2005;45:456-9.

13.

Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic Stroke. Arch Neurol. 2005;62:1217-20.

14.

Ruiz-Nodar JM, Marin F, Hurtado JF, et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis. J Am Coll Cardiol. 2008;51:818-25.

15.

Dewilde W, Ten Berg JM. Design and rationale of the WOEST trial: what is the optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation and coronary stenting. Am Heart J. 2009;158:713-8.

Titel: Safety of dual antiplatelet therapy in daily cardiology practice
Auteur: F. W. A. Verheugt
Publicatiedatum: 01-05-2010
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 5/2010
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03091767

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2010

The effect of insulin on the heart

Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium

Discrimination of the elderly: how guilty are you?

Towards a noninvasive anatomical and functional diagnostic work-up of patients with suspected coronary artery disease

Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands

Age is an independent risk factor for left atrial dysfunction: results from an observational study